Publications by authors named "Nicholas Rutland"

Claim this Profile
L
Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders.
Pinaki Bhattacharjee, Szabolcs Dvorácskó, Paul Volesky, Océane Pointeau, Nicholas Rutland

J Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders.
Pinaki Bhattacharjee, Szabolcs Dvorácskó, Océane Pointeau, Biswajit Kundu, Nicholas Rutland

Metabolism· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Sterol -Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential.
Pinaki Bhattacharjee, Nicholas Rutland, Malliga R Iyer

J Med Chem· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Pot Synthesis of Thio-Augmented Sulfonylureas via a Modified Bunte's Reaction.
Malliga R Iyer, Pinaki Bhattacharjee, Biswajit Kundu, Nicholas Rutland, Casey M Wood

ACS Omega· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL.
William H Parsons, Nicholas T Rutland, Jennifer A Crainic, Joaquin M Cardozo, Alyssa S Chow

Bioorg Med Chem Lett· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis